PSC clinical trials at UCSF
1 research study open to eligible people
Primary sclerosing cholangitis is a liver condition that slowly damages bile ducts. UCSF is building a large dataset from adult patient records, labs, and imaging for PSC. Researchers use these records to compare outcomes across patients and care settings.
Showing trials for
Global Prospective, Observational Cohort of Adult Patients With Primary Sclerosing Cholangitis (WIND-PSC Study)
open to eligible people ages 18-75
Develop an appropriate real-world data comparator cohort to support the design, execution, and serve as an external control for interventional clinical trials in PSC.
San Francisco, California and other locations
Our lead scientists for PSC research studies include Michael Li, MD, MPH.
Last updated: